Sensitivity of T-Leukemic Cells to Deoxyguanosine and Arabinosyl Guanine

  • Erwin W. Gelfand
  • Jacob W. W. Lee
  • Amos Cohen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 165)


The association of profound immunodeficiency with deficiencies of the purine enzymes adenosine deaminase (ADA) and purine nucleoside Phosphorylase (PNP) has revealed the important role of these metabolic pathways in the differentiation, maturation and proliferation of lymphoid cells.1 The selective interference of certain T-lymphocyte functions in PNP deficiency2 and the elevation of deoxyguanosine triphosphate (deoxyGTP) in patient erythrocytes3 has focused attention on the potential role of deoxyguanosine (GdR) in the pathogenesis of these events. Our initial studies identified significant differences between immature and mature T-cells in their response to GdR. Following incubation with GdR, immature T-cells fail to proliferate, rapidly accumulate deoxyGTP, and fail to eliminate the nucleotide.4


Ribonucleotide Reductase Purine Nucleoside Phosphorylase Chronic Myelogenous Leukemic Cell Deoxycytidine Kinase Adenosine Deaminase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D. W. Martin Jr., and E. W. Gelfand, Biochemistry of diseases of immunodevelopment, Ann. Rev. Bioch. 50: 845 (1981).CrossRefGoogle Scholar
  2. 2.
    E. W. Gelfand, H.-M. Dosch, W. D. Biggar and I. H. Fox, Partial purine nucleoside Phosphorylase deficiency: studies of lymphocyte function, J. Clin. Invest. 61: 1071 (1978).PubMedCrossRefGoogle Scholar
  3. 3.
    A. Cohen, D. Doyle, D. W. Martin and A. J. Ammann, Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside Phosphorylase, New Eng. J. Med. 295: 1449 (1976).PubMedCrossRefGoogle Scholar
  4. 4.
    A. Cohen, J. W. W. Lee, H.-M. Dosch, and E. W. Gelfand, The expression of deoxyguanosine toxicity in T lymphocytes at different stages of maturation, J. Immunol. 125: 1578 (1980).PubMedGoogle Scholar
  5. 5.
    B. S. Mitchell, C. A. Koller, and R. Heyn, Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo, Blood 56: 556 (1980).PubMedGoogle Scholar
  6. 6.
    E. W. Gelfand, A. Cohen, A. How, and H.-M. Dosch, Selectivity of nucleoside toxicity during T-cell ontogeny: Implications for therapy, Clin. Res. 28: 346 (1980).Google Scholar
  7. 7.
    A. Shore, H.-M. Dosch, and E. W. Gelfand, Expression and modulation of C3 receptors during early T-cell ontogeny, Cell. Immunol. 45: 157 (1979).PubMedCrossRefGoogle Scholar
  8. 8.
    B. S. Mitchell, E. Mejias, P. E. Daddona, and W. N. Kelly, Purinogenic immunodeficiency diseases: Selective toxicity of deoxyribonucleosides for T cells, Proc. Nat. Acad. Sci. 75: 5011 (1978).PubMedCrossRefGoogle Scholar
  9. 9.
    L. J. Gudas, B. Ullman, A. Cohen and D. W. Martin, Deoxy-guanosine toxicity in a mouse T lymphoma. Relationships to purine nucleoside Phosphorylase associated immune dysfunction, Cell 14: 531 (1978).PubMedCrossRefGoogle Scholar
  10. 10.
    E. W. Gelfand, J. W. W. Lee, and H. M. Dosch, Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function, Proc. Nat. Acad. Sci. 76: 1998 (1979).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Erwin W. Gelfand
    • 1
  • Jacob W. W. Lee
    • 1
  • Amos Cohen
    • 1
  1. 1.Division of Immunology Research InstituteThe Hospital for Sick ChildrenTorontoCanada

Personalised recommendations